Home
Into Bettermore Consulting
Bettermore News
Xiaomo future
Only you
网站设置
中文
中文
Home
Into Bettermore Consulting
Bettermore News
Bettermore Forum
Industry News
Clock in Bettermore
Xiaomo future
Growth Path
Personnel Training
Growth story
Only you
Internal recruitment
Contact us
Bettermore News
Bettermore Forum
Industry News
Clock in Bettermore
Bettermore News
百济神州 BTK 一季度全球销售突破 14 亿元,海外收入大涨超一倍
Time:2023-05-08
BIC疯狂,FIC崭露头角,热门靶点占半壁江山,中国2023潜力20亿新药都有谁?
Time:2023-04-24
神经病学竞技场,看顶级药企如何PK?
Time:2023-04-19
诺和诺德、礼来「领卷」GLP-1 赛道!信达、正大天晴、华东医药…国内市场硝烟四起
Time:2023-04-17
君实「特瑞普利单抗」第 7 项适应症报上市;恒瑞 ADC 新药启动新 III 期临床
Time:2023-04-17
丰百盛默春游记~
Time:2023-04-14
拜耳处方药业务加速创新,造福患者
Time:2023-04-03
石药 2022 年营收突破 300 亿元,首款国产新冠 mRNA 疫苗率先冲线!
Time:2023-03-27
星条旗下的宝藏:美国生物类似药市场2022概览
Time:2023-03-20
百济新宇宙开启
Time:2023-03-15
Home
Prev
1
2
3
4
5
6
Next
End
网站备案号:
沪ICP备19030974号-1
|© Bettermore. All rights reserved.